The Depression And Bladder Medicines That May Increase Dementia Risk

The more of these medications people were prescribed, the higher their rate of dementia diagnosis.

The more of these medications people were prescribed, the higher their rate of dementia diagnosis.

Anticholinergic drugs have been linked to a higher risk of dementia.

These drugs block the action of acetylcholine, a chemical messenger in the brain and body, and are used to treat depression, overactive bladder and symptoms of Parkinson’s disease.

For example, amitriptyline is an antidepressant formerly sold as Tryptizol in the UK and Elavil in the US.

Oxybutynin, used to treat overactive bladder, also has anticholinergic effects and comes in patches known as Kentera in the UK and Oxytrol in the US.

In a study of more than 217,000 people, each additional anticholinergic medicine prescribed at the start was associated with a 15 per cent higher rate of dementia diagnosis in the UK group and about a 6 per cent higher rate in the US group.

What the medicines share

Acetylcholine helps the brain pay attention, learn and form memories.

In the bladder, blocking certain acetylcholine signals can help control involuntary contractions.

Blocking those signals in the brain can make it harder to concentrate and may cause confusion.

Other tricyclic antidepressants with anticholinergic effects include clomipramine, known by the brand name Anafranil in both countries, and nortriptyline, known as Allegron in the UK and Pamelor in the US.

Paroxetine, an SSRI antidepressant with anticholinergic effects, has been sold as Seroxat in the UK and Paxil in the US.

Some antipsychotics also have these effects, including olanzapine, known as Zyprexa in both countries and used to treat schizophrenia and bipolar disorder.

The medicines have different uses, which makes their shared effect easy to overlook when someone takes several prescriptions for unrelated conditions.

How common were prescriptions?

Using a list of 88 medicines, the researchers counted how many each person had been prescribed at the start of the study.

They then looked at dementia diagnoses over a median of about 16 years in the UK Biobank and nine years in the US All of Us Research Program.

About a quarter of participants in the British group and just over a fifth of those in the American group had been prescribed at least one medicine on the list.

The increases were relative, and fewer than two in 100 participants in each group were diagnosed with dementia during follow-up.

The percentages describe how the rate of dementia diagnosis varied with the number of medicines prescribed and give no risk estimate for any individual drug.

Why cause remains unclear

A prescription can reveal something about a person’s health as well as what medicine they have been given.

Depression and Parkinson’s disease, for example, can lead to anticholinergic prescribing and are themselves associated with dementia risk.

The researchers could account for some differences in health between participants, but the reasons for prescribing and the severity of those conditions could still explain part of the association.

A count taken at the start also gives only a snapshot, since people may change medicines or stop taking them over the years.

For someone taking several prescriptions, a prescriber or pharmacist can review the full list and weigh the benefits and risks of each medicine in context.

The study was published in the journal Age and Ageing (Asiimwe et al., 2025).

Author: Dr Jeremy Dean

Psychologist, Jeremy Dean, PhD is the founder and author of PsyBlog. He holds a doctorate in psychology from University College London and two other advanced degrees in psychology. He has been writing about scientific research on PsyBlog since 2004.

Get free email updates

Join the free PsyBlog mailing list. No spam, ever.